Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email
NASDAQ:SCMP

(SCMP) (SCMP) Stock Price, News & Analysis

→ This Could be Your “Big Money” AI Moment (From InvestorPlace) (Ad)
Free SCMP Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$18.00
▼
$18.00
50-Day Range
$18.00
▼
$18.00
52-Week Range
$9.30
▼
$18.75
Volume
303,068 shs
Average Volume
2.56 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
SCMP stock logo

About (SCMP) Stock (NASDAQ:SCMP)

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products. Its primary focus areas are gastroenterology, ophthalmology and oncology-related disorders. Its product candidates include VTS-270, Lubiprostone (AMITIZA), Unoprostone is opropyl (RESCULA) and CPP-1X/sulindac combination product. VTS-270 is an investigational drug under clinical study for the treatment of Niemann-Pick Disease Type C-1, an ultra-orphan, progressive and fatal disease. AMITIZA is a ClC-2 chloride channel activator, which has been approved for three indications that cover distinct patient types: chronic idiopathic constipation, irritable bowel syndrome with constipation, and opioid-induced constipation. RESCULA is a Big Potassium channel activator used to lower intraocular pressure. CPP-1X/sulindac combination product is meant for the treatment of familial adenomatous polyposis (FAP).

SCMP Stock News Headlines

March 27, 2023 | financialpost.com
Alibaba founder Jack Ma returns to China, ending year-long sojourn abroad -SCMP
September 28, 2022 | reuters.com
ByteDance to add four directors to expand board to nine -SCMP - Reuters
September 20, 2022 | bloomberg.com
Hong Kong Reaches Consensus on Ending Hotel Quarantine: SCMP - Bloomberg
September 14, 2022 | reuters.com
PwC HK, KPMG to host U.S. regulator for China inspections -SCMP - Reuters
September 12, 2022 | bloomberg.com
Lithuania Set to Open Taipei Trade Office Tuesday, SCMP Reports - Bloomberg
September 12, 2022 | bloomberg.com
Lithuania Opens Taipei Trade Office Monday, SCMP Says - Bloomberg
September 10, 2022 | bloomberg.com
Five Hong Kongers Jailed for 19 Months Each for Sedition: SCMP - Bloomberg
August 17, 2022 | seekingalpha.com
Royal Caribbean seeks approval to sail in Hong Kong - SCMP (NYSE:RCL) - Seeking Alpha
August 3, 2022 | reuters.com
Zelenskiy seeking 'direct talks' with China's Xi to help end Ukraine war- SCMP - Reuters
July 30, 2022 | bloomberg.com
Hong Kong Rugby Sevens Set to Return in November, SCMP Says - Bloomberg
July 26, 2022 | financialpost.com
Hong Kong says may have to downgrade annual growth forecast in August - SCMP - Financial Post
July 22, 2022 | news.yahoo.com
Chinese President Xi Jinping wishes Joe Biden a speedy recovery from Covid-19 - Yahoo News
July 19, 2022 | bloomberg.com
Xi's Beijing Invite Unanswered by Top Europe Leaders, SCMP Says - Bloomberg
July 16, 2022 | finance.yahoo.com
Chinese military upgrades near disputed Himalayan border viewed as provocative in India - Yahoo Finance
July 12, 2022 | bloomberg.com
H.K. May Loosen Quarantine by November, Health Chief Tells SCMP - Bloomberg
July 10, 2022 | finance.yahoo.com
China presents US with further demands to improve relations at meeting between Foreign Minister Wang Yi and Secretary of State Antony Blinken - Yahoo Finance
July 10, 2022 | bloomberg.com
HK Mulls Health Code Similar to China to Fight Covid, SCMP Says - Bloomberg
July 6, 2022 | finance.yahoo.com
China ready for 'golden era' with the Philippines under Marcos Jnr - Yahoo Finance
June 26, 2022 | finance.yahoo.com
Under Xi Jinping China-Russia ties are defined by global interests and unity in opposition, report finds - Yahoo Finance
June 21, 2022 | reuters.com
Didi makes privacy fixes to ousted apps in run-up to restoring them - SCMP - Reuters
June 16, 2022 | bloomberg.com
Hong Kong Cuts Isolation Period for Handover Events, SCMP Says - Bloomberg
June 15, 2022 | npr.org
Was Hong Kong a colony? Not according to new textbooks, a newspaper says - NPR
June 12, 2022 | finance.yahoo.com
Japan calls for 'self-restraint' from China after joint fly-past with Russian fighter jets - Yahoo Finance
June 9, 2022 | finance.yahoo.com
Beijing hits out at Washington over proposed US$120 million arms deal to Taiwan - Yahoo Finance
June 9, 2022 | news.yahoo.com
Hong Kong to Isolate 1,000 People Before Any Xi Visit, SCMP Says - Yahoo News
See More Headlines

Company Calendar

Last Earnings
11/01/2017
Today
5/20/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:SCMP
CUSIP
86490910
CIK
1365216
Web
www.sucampo.com
Phone
+1-301-9613400
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Peter S. Greenleaf (Age 47)
    Chairman of the Board, Chief Executive Officer
  • Peter P. Pfreundschuh CPA (Age 48)
    Chief Financial Officer
  • Max Donley (Age 48)
    Executive Vice President of Global Human Resources, Information Technology and Strategy
  • Matthias Alder (Age 52)
    Executive Vice President
  • Peter A. Kiener Ph.D. (Age 64)
    Chief Scientific Officer
  • Alex Driggs (Age 41)
    General Counsel, Corporate Secretary
  • Peter Lichtlen M.D. (Age 47)
    Ph.D., Chief Medical Officer
  • John H. Johnson (Age 58)
    Lead Independent Director
  • Paul R. Edick (Age 62)
    Director
  • Daniel P. Getman Ph.D. (Age 59)
    Director

SCMP Stock Analysis - Frequently Asked Questions

How were (SCMP)'s earnings last quarter?

(SCMP) (NASDAQ:SCMP) released its earnings results on Wednesday, November, 1st. The biopharmaceutical company reported $0.27 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.25 by $0.02. The biopharmaceutical company had revenue of $61.27 million for the quarter, compared to analyst estimates of $58.05 million. (SCMP)'s quarterly revenue was up 5.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.30 earnings per share.

What other stocks do shareholders of (SCMP) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (SCMP) investors own include XOMA (XOMA), SentinelOne (S), Alnylam Pharmaceuticals (ALNY), Teekay Tankers (TNK), Xenon Pharmaceuticals (XENE), Gilead Sciences (GILD), OPKO Health (OPK), Cisco Systems (CSCO), Infinera (INFN) and Micron Technology (MU).

This page (NASDAQ:SCMP) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
"The Biggest Drug Ever" Is Coming
Behind the Markets
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
The 2024 Gold Rush: Unleashing Market Potential
Priority Gold
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1!
Huge Alerts
Warren Buffett's "mystery stock"
Stansberry Research
This Could be Your “Big Money” AI Moment
InvestorPlace
Digitizing the $11T commodities sector with one tiny stock
Resource Stock Digest
Elon to Transform U.S. Economy?
Porter & Company